Chemotherapy with benznidazole and itraconazole for mice infected with different Trypanosoma cruzi clonal genotypes

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 1, 2003, Pages 223-230

  De Ornelas Toledo, Max Jean ^c   Bahia, Maria Terezinha ^d   Carneiro, Cláudia M ^a   Martins Filho, Olindo Assis ^d   Tibayrenc, Michel ^b   Barnabé, Christian ^b   Tafuri, Washington Luis ^d   De Lana, Marta ^a  

^a FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

^b INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^c STATE UNIVERSITY OF MARINGÁ   (Brazil)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

BENZNIDAZOLE; ITRACONAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; MOUSE; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS;

ANIMALS; CHAGAS DISEASE; FEMALE; GENOTYPE; ITRACONAZOLE; MICE; MICE, INBRED BALB C; NITROIMIDAZOLES; PARASITIC SENSITIVITY TESTS; TRYPANOSOMA CRUZI;

EID: 4444317781     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.1.223-230.2003     Document Type: Article

References (42)

1. Andrade, S. G., J. B. Magalhães, and A. L. Pontes. 1985. Evaluation of chemotherapy with benznidazole and nifurtimox in mice infected with Trypanosoma cruzi strains of different types. Bull. W. H. O. 63:721-726.
2. Andrade, S. G., J. B. Magalhães, and A. L. Pontes. 1989. Terapêutica da fase crönica da infecção experimental pelo Trypanosoma cruzi com o benzonidazol e o nifurtimox. Rev. Soc. Bras. Med. Trop. 22:113-118.
3. Andrade, S. G., A. Rassi, J. B. Magalhães, F. Ferrioli Filho, and A. O. Luquetti. 1992. Specific chemotherapy of Chagas' disease: a comparison between the response in patients and experimental animals inoculated with the same strains. Trans. R. Soc. Trop. Med. Hyg. 86:624-626.
4. Andrade, S. G., and J. B. Magalhães. 1997. Biodemes and zymodemes of Trypanosoma cruzi strains: correlations with clinical data and experimental pathology. Rev. Soc. Bras. Med. Trop. 30:27-35.
5. Apt, B. W., X. Aguilera, A. Arribada, L. Gomez, M. A. Miles, and G. Widmer. 1987. Epidemiology of Chagas' disease in northern Chile: isoenzyme profiles of Trypanosoma cruzi from domestic and sylvatic transmission cycles and their association with cardiopathy. Am. J. Trop. Med. Hyg. 37:302-307.
6. Apt, B. W., X. Aguilera, A. Arribada, C. Pérez, C. Miranda, G. Sanchez, I. Zulantay, P. Cortés, J. Rodriguez, and D. Juri. 1998. Treatment of chronic Chagas' disease with itraconazole and allopurinol. Am. J. Trop. Med. Hyg. 59:133-138.
7. Barnabé, C., S. Brisse, and M. Tibayrenc. 2000. Population structure and genetic typing of Trypanosoma cruzi, the agent of Chagas disease: a multilocus enzyme electrophoresis approach. Parasitology, 150:513-526.
8. Brener, Z. 1962. Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi. Rev. Inst. Med. Trop. São Paulo 4:389-396.
9. Cançado, J. R. 2002. Long term evaluation of etiological treatment of Chagas disease with benznidazole. Rev. Inst. Med. Trop. São Paulo 44:29-37.
10. Carneiro, M., A. J. Romanha, and E. Chiari. 1991. Biological characterization of Trypanosoma cruzi strains from different zymodemes and schizodemes. Mem. Inst. Oswaldo Cruz 86:387-393.
11. Cordeiro, F. D., O. A. Martins-Filho, M. O. da Costa Rocha, S. J. Adad, R. Correia-Oliveira, and A. J. Romanha. 2001. Anti-Trypanosoma cruzi immunoglobulin G1 can be a useful tool for diagnosis and prognosis of human Chagas' disease. Clin. Diagn. Lab. Immunol. 8:112-118.
12. Coura, J. R., and S. L. Castro. 2002. A critical review on Chagas disease chemotherapy. Mem. Inst. Oswaldo Cruz 97:3-24.
13. Deane, M. P., H. L. Lenzi, and A. Jansen. 1984. Trypanosoma cruzi: vertebrate and invertebrate cycles in the same mammal host, the opossum Didelphis marsupialis. Mem. Inst. Oswaldo Cruz 79:513-515.
14. Dvorak, J. A., D. L. Hartman, and M. A. Miles. 1980. Trypanosoma cruzi: correlation of growth kinetics to zymodeme type in clones derived from various sources. J. Protozool. 27:472-474.
15. Filardi, L. S., and Z. Brener. 1987. Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease. Trans. R. Soc. Trop. Med. Hyg. 81:755-759.
16. Hudson, L., F. Grover, W. E. Gutteridge, R. A. Klein, W. Peters, R. A. Neal, M. A. Miles, M. T. Scott, R. Nourish, and B. P. Ager. 1983. Suggested guidelines for work with live Trypanosoma cruzi. Trans. R. Soc. Trop. Med. Hyg. 77:416-419.
17. Jaccard, P. 1908. Nouvelles recherches sur la distribution florale. Bull. Soc. Vaudoise Sci. Naturelles 44:223-270.
18. Lana, M., A. S. Pinto, C. Barnabé, V. Quesney, S. Noël, and M. Tibayrenc. 1998. Trypanosoma cruzi: compared vectorial transmissibility of three major clonal genotypes by Triatoma infestans. Exp. Parasitol. 89:1-5.
19. Laurent, J. P., C. Barnabé, V. Quesney, S. Noël, and M. Tibayrenc. 1997. Impact of clonal evolution on the biological diversity of Trypanosoma cruzi. Parasitology 114:213-218.
20. Lauria-Pires, L., A. R. Bogliolo, and A. R. L. Teixeira. 1996. Diversity of Trypanosoma cruzi stocks and clones derived from Chagas disease patients II. Isozyme and RFLP characterizations. Exp. Parasitol. 82:182-190.
21. Machado, C. A., and F. J. Ayala. 2001. Nucleotide sequences provide evidence of genetic exchange among distantly related lineages of Trypanosoma cruzi. Proc. Natl. Acad. Sci. USA 98:7396-7401.
22. Mantel, N. 1967. The detection of disease clustering and a generalized regression approach. Cancer Res. 27:209-220.
23. Martins-Filho, O. A., M. E. S. Pereira, J. Carvalho, J. R. Cançado, and Z. Brener. 1995. Flow cytometry, a new approach to detect anti-live trypomastigotes antibody and monitor the efficacy of specific treatment in human Chagas' disease. Clin. Diagn. Lab. Immunol. 2:569-573.
24. McCabe, R., J. Remington, and F. Araújo. 1986. In vitro and in vivo effects of itraconazole against Trypanosoma cruzi. Am. J. Trop. Med. Hyg. 35:280-284.
25. Miles, M. A., M. M. Povoa, A. A. De Souza, R. Lainson, J. J. Shaw, and D. S. Ketteridge. 1981. Chagas' disease in the Amazon Basin. II. The distribution of Trypanosoma cruzi zymodemes 1 and 3 in Para state, north Brazil. Trans. R. Soc. Trop. Med. Hyg. 75:667-674.
26. Miles, M. A., M. Povoa, A. Prata, R. A. Cedillos, A. A. De Souza, and V. Macedo. 1981. Do radically dissimilar Trypanosoma cruzi strains (zymodemes) cause Venezuelan and Brazilian forms of Chagas' disease? Lancet 8234:1336-1340.
27. Miles, M. A., B. W. Apt, G. Widmer, M. M. Povoa, and C. J. Schofield. 1984. Isozyme heterogeneity and numerical taxonomy of Trypanosoma cruzi stocks from Chile. Trans. R. Soc. Trop. Med. Hyg. 78:526-535.
28. Molina, J., O. A. Martins-Filho, Z. Brener, A. J. Romanha, D. Loebenberg, and J. A. Urbina. 2000. Activities of the triazole derivative SCH 56592 (posaconazole) against drug-resistant strain of the protozoan parasite Trypanosoma (Schizotrypanum) cruzi in immunocompetent and immunosuppressed murine hosts. Antimicrob. Agents Chemother. 44:150-155.
29. Molina, J., Z. Brener, A. J. Romanha, and J. A. Urbina. 2000. In vivo activity of the bis-triazole D0870 against drug-susceptible and drug-resistant strains of the protozoan parasite Trypanosoma cruzi. J. Antimicrob. Chemother. 46:137-140.
30. Momen, H. 1999. Taxonomy of Trypanosoma cruzi: a commentary on char. acterization and nomenclature. Mem. Inst. Oswaldo Cruz 94(Suppl. 1):181-184.
31. Murta, S. M. F., R. T. Gazzinelli, Z. Brener, and A. J. Romanha. 1998. Molecular characterization of susceptible and naturally resistant strains of Trypanosoma cruzi to benznidazole and nifurtimox. Mol. Biochem. Parasitol. 93:203-214.
32. Organización Panamericana de la Salud. 1994. Las condiciones de salud en las Américas. Publicación Científica (1) 549. Organización Panamericana de la Salud, Washington, D.C.
33. Revollo, S., B. Oury, J. P. Laurent, C. Barnabé, V. Quesney, V. Carrière, S. Noël, and M. Tibayrenc. 1998. Trypanosoma cruzi: impact of clonal evolution of the parasite on its biological and medical properties. Exp. Parasitol. 89:30-39.
34. Romanha, A. J., A. A. S. Pereira, E. Chiari, and V. Kilgour. 1979. Isoenzyme patterns of cultured Trypanosoma cruzi: changes after prolonged subculture. Comp. Biochem. Physiol. 62:139-142.
35. Souto, R. P., O. Fernandes, A. M. Macedo, D. A. Campbell, and B. Zingales. 1996. DNA markers define two major phylogenetic lineages of Trypanosoma cruzi. Mol. Biochem. Parasitol. 83:141-152.
36. Tibayrenc, M., and F. J. Ayala. 1988. Isozyme variability in Trypanosoma cruzi, the agent of Chagas' disease: genetical, taxonomical, and epidemiological significance. Evolution 42:277-292.
37. Tibayrenc, M., K. Neubauer, C. Barnabé, F. Guerrini, D. Skarecky, and F. J. Ayala. 1993. Genetic characterization of six parasitic protozoa: parity between random-primer DNA typing and multilocus enzyme electrophoresis. Proc. Natl. Acad. Sci. USA 90:1335-1339.
38. Tibayrenc, M. 1995. Population genetics of parasitic protozoa and other microorganisms, p. 47-115. In J. Baker, R. Muller, and D. E. Rollinson (ed.), Advances in parasitology. Academic Press, London, England.
39. Toledo, M. J. O., A. L. F. Guilherme, J. C. Silva, M. V. Gasperi, A. P. Mendes, M. L. Gomes, and S. Marques de Araújo. 1997. Trypanosoma cruzi: chemotherapy with benznidazole in mice inoculated with strains from Parana state and from different endemic areas of Brazil. Rev. Inst. Med. Trop. São Paulo 39:283-290.
40. Toledo, M. J. O., M. Lana, C. M. Carneiro, M. T. Bahia, G. L. L. MachadoCoelho, V. M. Veloso, C. Barnabé, M. Tibayrenc, and W. L Tafuri. 2002. Impact of Trypanosoma cruzi clonal evolution on its biological properties in mice. Exp. Parasitol. 100:161-172.
41. Urbina, J. 2001. Specific treatment of Chagas disease: current status and new developments. Curr. Opin. Infect. Dis. 14:717-718.
42. Voller, A., D. Bidwell, and A. Bartlet. 1980. Enzyme linked immunosorbent assay, p. 359-371. In N. R. Rose and R. Friedman (ed.), Manual of clinical immunology. American Society for Microbiology, Washington, D.C.